This segment focuses on providing a comprehensive range of pharmaceutical, biological, and nutritional products for pets, including dogs, cats, and other companion animals. Research and development efforts are directed towards developing innovative solutions for common pet health issues such as dermatology, parasitology, dental hygiene, and behavioral problems. Technologies employed include advanced vaccine development, novel drug delivery systems, and diagnostic tools for early disease detection. The goal is to improve the quality of life for pets and strengthen the bond between pets and their owners. Future opportunities include expanding the product portfolio with personalized medicine approaches and digital health solutions for remote monitoring and care.

This segment is dedicated to developing and marketing veterinary solutions for livestock, including cattle, swine, poultry, and aquaculture species. Research and development activities focus on preventing and treating diseases that affect farm animal productivity and welfare, such as respiratory infections, parasitic infestations, and metabolic disorders. Technologies used include advanced vaccine platforms, antimicrobial therapies, and nutritional supplements to optimize animal health and performance. The segment aims to support sustainable agriculture practices and ensure the safety and quality of food production. Future growth potential lies in developing innovative solutions for emerging diseases, improving animal welfare standards, and expanding into new markets with tailored product offerings.